EQL Pharma Investor Relations

Management

The CEO is subordinate to the board of directors and is responsible for the company’s day-to-day management and the day-to-day operation of the business. The division of responsibilities between the board of directors and the CEO is set out in the rules of procedure of the board of directors and the instruction for the CEO. The CEO is also responsible for preparing reports and compiling information from management prior to board meetings and is responsible for reporting on the material at board meetings. The CEO must ensure that the board of directors receives appropriate information to be able to evaluate the company’s financial position on an ongoing basis.

Axel Schörling

President and CEO

Shareholding
257,113 shares and 400,000 call options

Martin Kristofferson

COO

Shareholding
15,200 shares and 166,000 call options

Anna Jönsson

CFO

Shareholding
13,729 shares

Alexander Brising

Chief Commercial Officer

Shareholding
272,105 shares

Cornelia Lindström

Reg/QA/PV Director

Shareholding
46,000 call options

Carl Lindgren

Chief Business Development Officer

Shareholding
50,000 shares and 100,000 call options